Drug
Cyclopentolate
Cyclopentolate is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
25%
Ph phase_4
3
75%
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Terminated(1)
Other(2)
Detailed Status
unknown2
Completed1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 43 (75.0%)
Trials by Status
unknown250%
completed125%
withdrawn125%
Recent Activity
0 active trials
Showing 4 of 4
unknownphase_4
Cycloplegic Refraction in Pediatric Patients With Esotropia
NCT06077682
completedphase_4
Cycloplegic Refraction Among Children
NCT05442801
unknownphase_4
A New More Efficient Cycloplegia Scheme
NCT02177539
withdrawnphase_1
Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children?
NCT00348166
Clinical Trials (4)
Showing 4 of 4 trials
NCT06077682Phase 4
Cycloplegic Refraction in Pediatric Patients With Esotropia
NCT05442801Phase 4
Cycloplegic Refraction Among Children
NCT02177539Phase 4
A New More Efficient Cycloplegia Scheme
NCT00348166Phase 1
Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children?
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4